Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2020-05
Metadata
Show full item recordOther Titles
MS update: risk factors, diagnosis and treatmentCitation
Haukur Hjaltason, Ólafur Sveinsson. Nýjungar í MS: Áhættuþættir, greining og meðferð. Læknablaðið. 2020; 106(5): 241-246.Abstract
MS (multiple sclerosis) er algengasti bólgusjúkdómurinn í miðtaugakerfi og ein algengasta orsök fötlunar hjá ungu og miðaldra fólki. MS er sjálfsofnæmissjúkdómur sem orsakast af flóknu samspili erfða og umhverfis. Miklar framfarir hafa orðið í greiningu og meðferð sjúkdómsins á síðustu árum og mikilvægt er að læknar séu vel upplýstir um einkenni og meðferðarmöguleika til að tryggja skjóta greiningu og viðeigandi meðferð. Í þessari grein ræðum við nýjungar í orsökum, greiningu og meðferð MS.Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system and among the most common causes of neurological disability in young and middle-aged adults. MS is an autoimmune disease caused by a complex interaction between genetic and environmental factors. During the last decades, great advances have been made in understanding the risk factors of MS and the diagnostic ability and treatment of the disease have improved dramatically. It is of importance that doctors are made aware of the possibility of an early diagnosis and effective treatment. In this paper we discuss new knowledge regarding the etiology, diagnosis and treatment of MS.
Description
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked DownloadAdditional Links
https://www.laeknabladid.is/tolublod/2020/05/nr/7337Collections